Phytochemicals as Lead Compounds for New Drug Discovery
Egbuna, Chukwuebuka
Kumar, Shashank
Ifemeje, Jonathan C.
Ezzat, Shahira M.
Kaliyaperumal, Saravanan
Phytochemicals as Lead Compounds for New Drug Discovery presents complete coverage of the recent advances in the discovery of phytochemicals from medicinal plants as models to the development of new drugs and chemical entities. Functional bioactive compounds of plant origin have been an invaluable source for many human therapeutic drugs and have played a major role in the treatment of diseases around the world. These compounds possess enormous structural and chemical diversity and have led to many important discoveries. This book presents fundament concepts and factors affecting the choice for plant-based products, as well as recent advances in computer-aided drug discovery and FDA drug candidacy acceptance criteria. It also details the various bioactive lead compounds and molecular targets for a range of life-threatening diseases including cancer, diabetes, and neurodegenerative diseases. Written by a global team of experts, Phytochemicals as Lead Compounds for New Drug Discovery is an ideal resource for drug developers, phytochemists, plant biochemists, food and medicinal chemists, nutritionists and toxicologists, chemical ecologists, taxonomists, analytical chemists, and other researchers in those fields. It will also be very valuable to professors, students, and researchers in this domain. Presents fundamental concepts and factors affecting choice for plant-based productsDetails the FDA drug candidacy acceptance criteria, including bottlenecks and way forwardHighlights recent advances in computational-based drug discoveryFocuses on the discovery of new drugs and potential druggable targets for the treatment of chronic diseases of world importance INDICE: Part I: Plants As Natural Sources Of Drugs 1. Plant Secondary Metabolites as Lead Compounds for the Production of Potent Drugs 2. Factors Affecting the Choice for Plant-based Products in Drug Discoveries 3. Advances in Computer-Aided Drug Discovery 4. FDA drug candidacy acceptance criteria and steps: Problems and way forward Part II: Bio-functional Leads for Drug Development 5. Bioactive lead compounds and molecular targets for the treatment of heart diseases 6. Natural bioactive lead compounds effective against haematological malignancies 7. Adjunct Therapeutic Potential of Phytochemicals Against Cancer 8. Anti-diabetic lead compounds and targets for drug development 9. Anti-obesity functional leads and targets for drug development 10. Phytochemicals as therapeutic interventions in neurodegenerative diseases 11. Organosulfur phytochemicals against metabolic and neurodegenerative diseases: Benefits and risks 12. Lead compounds with the potentials for the treatment of chronic liver diseases 13. Phytocompounds and potential target sites against skin diseases 14. Phytochemicals as emerging therapeutic agents for alopecia treatment 15. Antiviral phytocompounds for drug development: A data mining studies 16. Shikimic acid as intermediary model for the production of drugs effective against influenza virus 17. Antimicrobial Lead Compounds from Marine Plants 18. Antibacterial lead compounds and targets for drug development 19. Awareness and Current Therapeutic Strategies of Malaria 20. Bioactive lead compounds and targets for the development of anti-malarial drugs 21. Bioactive lead compounds and targets for the development of anti-inflammatory drugs 22. Functional lead compounds and targets for the development of drugs for the treatment of male infertility 23. Prenylated flavonoids as a promising drug discovery candidate: A pharmacological update
- ISBN: 978-0-12-817890-4
- Editorial: Elsevier
- Encuadernacion: Rústica
- Páginas: 515
- Fecha Publicación: 06/01/2020
- Nº Volúmenes: 1
- Idioma: Inglés